<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SILDENAFIL CITRATE <img border="0" src="../images/pr.gif"/></span><br/>(sil-den'a-fil ci'trate)<br/><span class="topboxtradename">Revatio, Viagra<br/></span><b>Classifications:</b> <span class="classification">impotence agent</span>; <span class="classification">phosphodiesterase (pde) inhibitor</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg, 25 mg, 50 mg, 100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Oral treatment for erectile dysfunction, whether organic or psychogenic in origin.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Enhances vasodilation effect of nitric oxide in the corpus cavernosus of the penis, thus sustaining an erection.</p>
<h1><a name="uses">Uses</a></h1>
<p>Erectile dysfunction, pulmonary arterial hypertension.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to sildenafil; concurrent administration of organic nitrates and nitroglycerin; pregnancy (category B); lactation.
         Not recommended for women or children.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>CAD, heart failure, MI, cardiac arrhythmias, stroke within 6 mo of starting drug; hypotension and hypertension; risk factors
         for CVA; aortic stenosis; anatomic deformity of the penis; sickle cell anemia, polycythemia; multiple myeloma; leukemia; active
         bleeding or a peptic ulcer; GERD, hiatal hernia; coagulopathy; retinitis pigmentosa; hepatic disease, hepatitis, cirrhosis;
         severe renal impairment (Cl<sub>cr</sub>
</p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Erectile Dysfunction</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 50 mg 0.54 h before sexual activity (dose range: 25 to 100 mg once/d); max dose: 25 mg/d with itraconazole or ketoconazole;
               max dose: 25 mg/48 h with ritonavir<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 25 mg approximately 1 h before sexual activity<br/><br/><span class="indicationtitle">Pulmonary Arterial Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 20 mg t.i.d. (46 h apart)<br/><br/><span class="indicationtitle">Hepatic or Severe Renal Impairment</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25 mg approximately 1 h before sexual activity<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>For ED: Dose 1 h prior to sexual activity (effective range is 0.54 h).</li>
<li>Do not give within 24 h of taking any medication with nitrates (i.e., nitroglycerine).</li>
<li>Store at 15°30° C (59°86° F) in a tightly closed container; protect from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Face edema, photosensitivity, shock, asthenia, pain, chills, fall, allergic reaction, arthritis, myalgia. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache,</span> dizziness, migraine, syncope, cerebral thrombosis, ataxia, neuralgia, paresthesias, tremor, vertigo, depression, insomnia,
      somnolence, abnormal dreams. <span class="typehead">CV:</span> Flushing, chest pain, <span class="speceff-life">MI</span>, angina, AV block, tachycardia, palpitation, hypotension, postural hypotension, <span class="speceff-life">cardiac arrest</span>, <span class="speceff-life">sudden cardiac death</span>, heart failure, cardiomyopathy, abnormal ECG, edema. <span class="typehead">GI:</span> Dyspepsia, diarrhea, abdominal pain, vomiting, colitis, dysphagia, gastritis, gastroenteritis, esophagitis, stomatitis, dry
      mouth, abnormal liver function tests, thirst. <span class="typehead">Respiratory:</span> Nasal congestion, asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, cough. <span class="typehead">Skin:</span> Rash, urticaria, pruritus, sweating, <span class="speceff-life">exfoliative dermatitis</span>. <span class="typehead">Urogenital:</span> UTI. <span class="typehead">Special Senses:</span> Abnormal vision (color changes, photosensitivity, blurred vision, sudden vision loss). <span class="typehead">Hematologic:</span> Anemia, leukopenia. <span class="typehead">Metabolic:</span> Gout, hyperglycemia, hyperuricemia, hypoglycemia, hypernatremia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">nitrates</span> increase risk of serious hypotension; if used within 4 h of <b>doxazosin,</b>
<b>prazosin,</b>
<b>terazosin,</b>
<b>tamsulosin;</b>
<b>cimetidine,</b>
<b>erythromycin,</b>
<b>ketoconazole,</b>
<b>itraconazole,</b>
<span class="classification">protease inhibitors</span> increase sildenafil levels; <b>rifampin</b> can decrease sildenafil levels. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Peak:</span> 30120 min. <span class="typehead">Distribution:</span> 96% protein bound. <span class="typehead">Metabolism:</span> Metabolized in liver by cytochromes P450 3A4 (primary) and 2C9 (minor). <span class="typehead">Elimination:</span> 80% excreted in feces, 12% in urine. <span class="typehead">Half-Life:</span> 4 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor carefully for and immediately report S&amp;S of cardiac distress.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not take sildenafil within 4 h of taking doxazosin, prazosin, terazosin, or tamsulosin.</li>
<li>Consuming a high-fat meal before taking drug may cause delay in drug action.</li>
<li>Report to physician: Headaches, flushing, chest pain, indigestion, blurred vision, sensitivity to light, changes in color
            vision.
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>